Biosynthesis of acylceramide in murine epidermis: Characterization by inhibition of glucosylation and deglucosylation, and by substrate specificity

Journal of Investigative Dermatology

Volumn 122, Issue 3, 2004, Pages 722-729

  Takagi, Yutaka ^a   Nakagawa, Hidemi ^a   Matsuo, Noboru ^b   Nomura, Tomoko ^b   Takizawa, Minoru ^b   Imokawa, Genji ^b,c  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b Kao Biological Science Laboratories   (Japan)

^c Kao Biological Science Laboratories   (Japan)

Author keywords

Acylation; Barrier function; Ceramide; Glucosylceramide; Stratum corneum; hydroxylation

Indexed keywords

ACYLCERAMIDE; ACYLGLUCOSYLCERAMIDE; ACYLTRANSFERASE; CARBON 14; CERAMIDE DERIVATIVE; CERAMIDE GLUCOSYLTRANSFERASE; CONDURITOL B EPOXIDE; ENZYME INHIBITOR; GLUCOSYLCERAMIDASE; HYDROXY FATTY ACID; OMEGA HYDROXYCERAMIDE; OMEGA HYDROXYGLUCOSYLCERAMIDE; SERINE; SPHINGOSINE; THREO 1 PHENYL 2 DECANOYLAMINO 3 MORPHOLINO 1 PROPANOL; UNCLASSIFIED DRUG;

ACYLATION; ANIMAL TISSUE; ARTICLE; CATTLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SPECIFICITY; EPIDERMIS; FATTY ACID SYNTHESIS; GLYCOSYLATION; HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY; HYDROXYLATION; IN VITRO STUDY; MALE; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; STRATUM CORNEUM;

EID: 1842639380     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0022-202X.2004.22307.x     Document Type: Article

References (28)

1. Behne M, Uchida Y, Seki T, de Montellano PO, Elias PM, Holleran WM: Omega-hydroxyceramides are required for comeocyte lipid envelope (CLE) formation and normal epidermal permeability barrier function. J Invest Dermatol 114:185-192, 2000
2. Bligh EG, Dyer WJ: A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37:911-917, 1959
3. Coste H, Martel MB, Azzar G, Got R: UDPglucose-ceramide glucosyltransferase from porcine submaxillary glands is associated with the Golgi apparatus. Biochim Biophys Acta 814:1-7, 1985
4. Doering T, Proia RL, Sandhoff K: Accumulation of protein-bound epidermal glucosylceramides in beta-glucocerebrosidase deficient type 2 Gaucher mice. FEBS Lett 447:167-170, 1999
5. Hara J, Higuchi K, Okamoto R, Kawashima M, Imokawa G: High-expression of sphingomyelin deacylase is an important determinant of ceramide deficiency leading to barrier disruption in atopic dermatitis. J Invest Dermatol 115:406-113, 2000
6. Higuchi K, Hara J, Okamoto R, Kawashima M, Imokawa G: The skin of atopic dermatitis patients contains a novel enzyme, glucosylceramide sphingomyelin deacylase, which cleaves the N-acyl linkage of sphingomyelin and glucosylceramide. Biochem J 350:747-756, 2000
7. Hiraoka M, Abe A, Shayman JA: Cloning and characterization of a lysosomal phosphollpase A2, 1-O-acylceramide synthase. J Biol Chem 277:10090-10099, 2002
8. Holleran WM, Takagi Y, Imokawa G, Jackson S, Lee JM, Elias PM: Beta-glucocerebrosidase activity in murine epidermis: Characterization and localization in relation to differentiation. J Lipid Res 33:1201-1209, 1992
9. Holleran WM, Ginns EI, Menon GK, et al: Consequence of beta-glucocerebrosidase deficiency in epidermis. Ultrastructure and permeability barrier alterations in Gaucher disease. J Clin Invest 93:1756-1764, 1994
10. Imokawa G: Skin moisturizers: Development and clinical use of ceramides. In: Loden M (ed). Dry Skin and Moisturizers. Boca Ratron, FL: CRC Press, 1999; p 269-299
11. Imokawa G: Lipid abnormalities in atopic dermatitis. J Am Acad Dermatol 45:S29-S32, 2001
12. Imokawa G, Abe A, Jin K, Higaki Y, Kawashima M, Hidano A: Decreased level of ceramides In stratum corneum of atopic dermatitis: An etiologic factor in atopic dry skin? J Invest Dermatol 96:523-526, 1991
13. Imokawa G, Yada Y, Higuchi K, Okuda M, Ohashi Y, Kawamata A: Pseudoacylceramide with linoleic acid produces selective recovery of diminished cutaneous barrier function in essential fatty acid deficient rats and has an inhibitory effect on epidermal hyperplasia. J Clin Invest 94:89-96, 1994
14. Inokuchi J, Radin NS: Preparation of the active isomer of 1-phenyl-2-decanoylamino-3-morpholino-1-propanol, inhibitor of murine glucocerebroside synthetase. J Lipid Res 28:565-571, 1987
15. Kondo H, Ichikawa Y, Imokawa G: Percutaneous sensitization with mite antigens elicits Th2-dominant cytokine response in a cutaneous barrier-disrupted model. Eur J Immunol 28:769-779, 1998
16. Marekov LN, Steinert PM: Ceramides are bound to structural proteins of the human foreskin epidermal cornified cell envelope. J Biol Chem 273:17763-17770, 1998
17. Melton J, Wertz PW, Swartzendruber DC, Downing DT: Effects of essential fatty add deficiency on epidermal O-acyl-sphingolipids and transepidermal water loss in young pigs. Biochim Biophys Acta 921:191-197, 1987
18. Mori K, Matsuda H: Synthesis of (2S,3R,4E)-1-O-(beta-D-glucopyranosyl)-N- [30′-(linoleoyloxy)triacontanoyl]-4-isocasphingenine, a new esterified cerebroside isolated from human and pig epidermis. Liebigs Ann Chem 1991:529-535, 1991
19. Murata Y, Ogata J, Higaki Y, Kawashima M, Imokawa G: Abnormal expression of sphingomyelin acylase in atopic dermatitis: An etiologic factor for ceramide deficiency? J Invest Dermatol 106:1242-1249, 1996
20. Nemes Z, Marekov LN, Fesus L, Steinert PM: A novel function for transglutaminase 1: Attachment of long-chain ω-hydroxyceramides to involucrin by ester bond formation. Proc Natl Acad Sci USA 96:8402-8407, 1999
21. Ortiz de Montellano PR: Cytochrome P450. Structure, Mechanism, and Biochemistry, 2nd edn. New York: Plenum Press, 1995; p 305-364
22. Ponec MA, Weerheim A, Kempenaar J, Mommaas A-M, Nugteren DA: Lipid composition of cultured human keratinocytes in relation to their differentiation. J Lipid Res 29:949-961, 1988
23. Radian R, Kanner BI: Reconstitution and purification of the sodium-and chloride-coupled gamma-aminobutyric acid transporter from rat brain. J Biol Chem 260:11859-11865, 1985
24. Schmuth M, Man MQ, Weber F, et al: Permeability barrier disorder in Niemann-Pick disease: Sphingomyelin-ceramide processing required for normal barrier homeostasis. J Invest Dermatol 115:459-466, 2000
25. Sidransky E, Fartasch M, Lee RE, et al: Epidermal abnormalities may distinguish type 2 from type 1 and type 3 of Gaucher disease. Pediatr Res 39:134-141, 1996
26. Takagi Y, Kriehuber E, Imokawa G, Elias PM, Holleran WM: beta-Glucocerebrosidase activity in mammalian stratum corneum. J Lipid Res 40:861-869, 1999
27. Uchida Y, Hara M, Nishio H, et al: Epidermal sphingomyelins are precursors for selected stratum corneum ceramides. J Lipid Res 41:2071-2082, 2000
28. Umeda Y, Mizutani H, Imokawa G, Shimizu M: Topical ceramide corrected epidermal cell hyperproliferation and stratum corneum dysmaturation in atopic eczema. New Trends Allergy 4:237-239, 1997